Alzheimer's Disease Drug Discovery Targeted to the APP mRNA 5'Untranslated Region

By Rogers J.T.   Randall J.D.   Eder P.S.   Huang X.   Bush A.I.   Tanzi R.E.   Venti A.   Payton S.M.   Giordano T.   Nagano S.   Cahill C.M.   Moir R.   Lahiri D.K.   Greig N.   Sarang S.S.   Gullans S.R.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 77-82

Humana Press, Inc

Access to resources Recommend Favorite

Drug discovery targeted to the Alzheimer’s APP mRNA 5′-untranslated region: The action of paroxetine and dimercaptopropanol

By Payton Sandra   Cahill Catherine   Randall Jeffrey   Gullans Steven   Rogers Jack  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 267-275

Humana Press, Inc

Access to resources Recommend Favorite

Heterozygous mutation in 5’-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia

By Steinberger Daniela   Blau Nenad   Goriuonov Dimitri   Bitsch Juliane   Zuker Michael   Hummel Sibylla   Müller Ulrich  

Neurogenetics, Vol. 5, Iss. 3, 2004-09 ,pp. : 187-190

Springer Publishing Company

Access to resources Recommend Favorite

Transcript map of the candidate region for HSNI with cough and gastroesophageal reflux on chromosome 3p and exclusion of candidate genes

By Kok Cindy   Kennerson Marina   Myers Simon   Nicholson Garth  

Neurogenetics, Vol. 5, Iss. 3, 2004-09 ,pp. : 197-200

Springer Publishing Company

Access to resources Recommend Favorite

Pilot Study of the Reducing Effect on Amyloidosis In Vivo by Three FDA Pre-Approved Drugs Via the Alzheimer's APP 5'Untranslated Region

By  

Current Alzheimer Research, Vol. 2, Iss. 2, 2005-04 ,pp. : 249-254

Bentham Science Publishers

Access to resources Recommend Favorite